Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Noha Mousaad Elemam, Suad Hannawi & Azzam A Maghazachi. (2020) Role of Chemokines and Chemokine Receptors in Rheumatoid Arthritis. ImmunoTargets and Therapy 9, pages 43-56.
Read now
Read now
Articles from other publishers (19)
Nuno Vale, Mariana Pereira & Rui Amaral Mendes. (2023) Systemic Inflammatory Disorders, Immunosuppressive Treatment and Increase Risk of Head and Neck Cancers—A Narrative Review of Potential Physiopathological and Biological Mechanisms. Cells 12:17, pages 2192.
Crossref
Crossref
Weile Chen, Yilong Fang, Huihui Wang, Xuewen Tan, Xiangling Zhu, Zhen Xu, Haifeng Jiang, Xuming Wu, Wenming Hong, Xinming Wang, Jiajie Tu & Wei Wei. (2023) Role of chemokine receptor 2 in rheumatoid arthritis: A research update. International Immunopharmacology 116, pages 109755.
Crossref
Crossref
Konstantin Kotschenreuther, Shuaifeng Yan & David M. Kofler. (2022) Migration and homeostasis of regulatory T cells in rheumatoid arthritis. Frontiers in Immunology 13.
Crossref
Crossref
Jianan Zhao, Kai Wei, Ping Jiang, Cen Chang, Lingxia Xu, Linshuai Xu, Yiming Shi, Shicheng Guo & Dongyi He. (2022) G-Protein-Coupled Receptors in Rheumatoid Arthritis: Recent Insights into Mechanisms and Functional Roles. Frontiers in Immunology 13.
Crossref
Crossref
V. V. Rybakova, A. S. Avdeeva, D. A. Dibrov & Е. L. Nasonov. (2022) Relationship of cytokine level dynamics with longterm results of early rheumatoid arthritis therapy. Rheumatology Science and Practice 60:1, pages 72-79.
Crossref
Crossref
Christina Drevinge, Julia M Scheffler, Catalin Koro-Arvidsson, Daniel Sundh, Hans Carlsten, Inger Gjertsson, Catharina Lindholm, Mattias Lorentzon, Anna Rudin, Anna-Karin Hultgård Ekwall & Ulrika Islander. (2021) Intermediate monocytes correlate with CXCR3+ Th17 cells but not with bone characteristics in untreated early rheumatoid arthritis. PLOS ONE 16:3, pages e0249205.
Crossref
Crossref
Georgios K. Vasileiadis, Anna-Carin Lundell, Yuan Zhang, Kerstin Andersson, Inger Gjertsson, Anna Rudin & Cristina Maglio. (2021) Adipocytokines in Untreated Newly Diagnosed Rheumatoid Arthritis: Association with Circulating Chemokines and Markers of Inflammation. Biomolecules 11:2, pages 325.
Crossref
Crossref
Kyle Gettler, Mamta Giri, Ephraim Kenigsberg, Jerome Martin, Ling-Shiang Chuang, Nai-Yun Hsu, Lee A. Denson, Jeffrey S. Hyams, Anne Griffiths, Joshua D. Noe, Wallace V. Crandall, David R. Mack, Richard Kellermayer, Clara Abraham, Gabriel Hoffman, Subra Kugathasan & Judy H. Cho. (2019) Prioritizing Crohn’s disease genes by integrating association signals with gene expression implicates monocyte subsets. Genes & Immunity 20:7, pages 577-588.
Crossref
Crossref
Simone L VerweijRaphaël DuivenvoordenLotte C A StiekemaNick S NurmohamedFleur M van der ValkMiranda VerslootHein J VerberneErik S G StroesMatthias Nahrendorf, Siroon BekkeringSophie J Bernelot Moens. (2018) CCR2 expression on circulating monocytes is associated with arterial wall inflammation assessed by 18F-FDG PET/CT in patients at risk for cardiovascular disease. Cardiovascular Research 114:3, pages 468-475.
Crossref
Crossref
Jayesh M. Pandya, Anna-Carin Lundell, Kerstin Andersson, Inger Nordström, Elke Theander & Anna Rudin. (2017) Blood chemokine profile in untreated early rheumatoid arthritis: CXCL10 as a disease activity marker. Arthritis Research & Therapy 19:1.
Crossref
Crossref
Neelakshi R. Jog & Judith A. James. (2017) Biomarkers in connective tissue diseases. Journal of Allergy and Clinical Immunology 140:6, pages 1473-1483.
Crossref
Crossref
Roy M. Fleischmann, Frank Wagner, Alan J. Kivitz, Heikki T. Mansikka, Nasser Khan, Ahmed A. Othman, Amit Khatri, Feng Hong, Ping Jiang, Melanie Ruzek & Robert J. Padley. (2017)
Safety, Tolerability, and Pharmacodynamics of
ABT
‐122, a Tumor Necrosis Factor– and Interleukin‐17–Targeted Dual Variable Domain Immunoglobulin, in Patients With Rheumatoid Arthritis
. Arthritis & Rheumatology 69:12, pages 2283-2291.
Crossref
Crossref
Bobby Kwanghoon Han, Igor Kuzin, John P. Gaughan, Nancy J. Olsen & Andrea Bottaro. (2016) Baseline CXCL10 and CXCL13 levels are predictive biomarkers for tumor necrosis factor inhibitor therapy in patients with moderate to severe rheumatoid arthritis: a pilot, prospective study. Arthritis Research & Therapy 18:1.
Crossref
Crossref
Iria V. Seoane, Ana M. Ortiz, Lorena Piris, Amalia Lamana, Yasmina Juarranz, Rosario García-Vicuña, Isidoro González-Álvaro, Rosa P. Gomariz & Carmen Martínez. (2016) Clinical Relevance of VPAC1 Receptor Expression in Early Arthritis: Association with IL-6 and Disease Activity. PLOS ONE 11:2, pages e0149141.
Crossref
Crossref
João Luiz Pereira Vaz, Vander Fernandes, Felipe Nogueira, Adriano Arnóbio & Roger A. Levy. (2015) Infliximab-induced autoantibodies: a multicenter study. Clinical Rheumatology 35:2, pages 325-332.
Crossref
Crossref
Fernanda Genre, Raquel López-Mejías, José A. Miranda-Filloy, Begoña Ubilla, Verónica Mijares, Beatriz Carnero-López, Inés Gómez-Acebo, Trinidad Dierssen-Sotos, Sara Remuzgo-Martínez, Ricardo Blanco, Trinitario Pina, Carlos González-Juanatey, Javier Llorca & Miguel A. González-Gay. (2015) Anti-TNF-α therapy reduces endothelial cell activation in non-diabetic ankylosing spondylitis patients. Rheumatology International 35:12, pages 2069-2078.
Crossref
Crossref
Rossella Talotta, Angela Berzi, Fabiola Atzeni, Alberto Batticciotto, Mario Clerici, Piercarlo Sarzi-Puttini & Daria Trabattoni. (2015) Paradoxical Expansion of Th1 and Th17 Lymphocytes in Rheumatoid Arthritis Following Infliximab Treatment: a Possible Explanation for a Lack of Clinical Response. Journal of Clinical Immunology 35:6, pages 550-557.
Crossref
Crossref
Darren L. Asquith, Steven A. Bryce & Robert J.B. Nibbs. (2015) Targeting cell migration in rheumatoid arthritis. Current Opinion in Rheumatology 27:2, pages 204-211.
Crossref
Crossref
Tatsuhiko Saito, Kei Ohnuma, Hiroshi Suzuki, Nam H. Dang, Ryou Hatano, Hiroki Ninomiya & Chikao Morimoto. (2013) Polyarthropathy in type 2 diabetes patients treated with DPP4 inhibitors. Diabetes Research and Clinical Practice 102:1, pages e8-e12.
Crossref
Crossref